Are you a professional?

The succeeding information is targeted to healthcare professionals with authorization for dispensing or prescribing medication.

If you continue, you accept being a professional of the abovementioned sector.

Go back
Client access

Cenmetasona 2 mg/ml

Anti-inflammatory / Antipyretic

Cenmetasona 2 mg/ml
Injectable

Injectable Dexamethasone

Pharmaceutical form

Injectable solution

Target species

Cattle / Swine / Horses / Dogs / Cats

Registry Num.

2692 ESP

Pack sizes

50ml and 100ml bottles

Composition

Each ml contains:

Active substance:

Dexamethasone (as dexamethasone sodium phosphate)

2.0 mg

Excipients:

Benzyl alcohol (E-1519)

15.6 mg

For the full list of excipients, see section 6.1.

Indications for use

Horses, cattle, pigs, dogs and cats

Treatment of inflammatory or allergic conditions.

Cattle

Induction of labour.
Treatment of primary ketosis.

Horses

Treatment of arthritis, bursitis or synovitis.

Diseases

  • Muscle-skeletals affections
  • Allergy
  • Ketosis (Acetonaemia)

Posology and administration via

Horses, cattle, pigs

0.06 mg/kg body weight, which corresponds to 1.5 ml/50 kg

Dogs and cats

0.1 mg/kg body weight, which corresponds to 0.5 ml/10 kg


Doses may be repeated once at intervals of 24 to 48 hours if necessary. When it is necessary to repeat the dose, the injection sites should be alternated.

Horses

Administration by intravenous, intramuscular or intra-articular route.

Cattle, pigs, dogs and cats

Intramuscular administration.

Withdrawal periods

Cattle

Meat: 8 days
Milk: 72 hours

Pigs

Meat: 2 days
Horses: 12 days

Horses

8 days

Remarks

Except in emergency situations, do not use in animals suffering from diabetes mellitus, chronic nephritis, renal failure, heart failure or osteoporosis.
Do not use in viral infections during the viraemic phase or in cases of systemic fungal infections.
Do not use in animals with gastrointestinal or corneal ulcers, nor in individuals with demodicosis.
Do not administer intra-articularly if there are fractures, bacterial infections in the joints or bone necrosis.
Do not use in cases of known hypersensitivity to the active substance, corticosteroids or any of the excipients.
See also section 4.7.

Downloads

SPC-AEMPS (AEMPS)

Promotional brochure

Cenmetasona